Literature DB >> 8005195

The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate.

H Knauf1, W Cawello, G Schmidt, E Mutschler.   

Abstract

The effect of the thiazide diuretic, bemetizide, on the excretion of Na+, K+, Cl-, Ca2+, and Mg2+ in relation to the glomerular filtration rate (GFR) was studied in 17 subjects whose creatinine clearances ranged from 133 to 5 ml.min-1. After a 2-day fluid and salt balanced control period, 25 mg bemetizide given orally induced natriuresis and kaliuresis which lasted for 24 h and were proportional to the GFR of the patients. The ratio of bemetizide-induced K+/Na+ excretion was always 0.17 irrespective of individual GFR. In renal failure, bemetizide increased the fractional Na+ excretion from 3% to about 10%. Kaliuresis was associated with magnesiuria, whereas bemetizide-induced calciuresis was insignificant. The thiazide reversibly lowered GFR in all subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005195     DOI: 10.1007/BF00195908

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.

Authors:  B Sigurd; K H Olesen; A Wennevold
Journal:  Am Heart J       Date:  1975-02       Impact factor: 4.749

2.  Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Thiazide-sensitive sodium chloride cotransport in early distal tubule.

Authors:  D H Ellison; H Velázquez; F S Wright
Journal:  Am J Physiol       Date:  1987-09

5.  A comparison of the effects of hydrochlorothiazide and hydrochlorothiazide in combination with triamterene on electrolyte balance.

Authors:  P J Tannenbaum; A P Crosley
Journal:  Clin Pharmacol Ther       Date:  1966 Nov-Dec       Impact factor: 6.875

Review 6.  Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Thiazide diuretic agents and the incidence of hip fracture.

Authors:  A Z LaCroix; J Wienpahl; L R White; R B Wallace; P A Scherr; L K George; J Cornoni-Huntley; A M Ostfeld
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

8.  Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.

Authors: 
Journal:  Arch Intern Med       Date:  1981-03

9.  Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.

Authors:  J W Hollifield
Journal:  Am J Med       Date:  1986-04-25       Impact factor: 4.965

10.  Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.

Authors:  E Keller; G Hoppe-Seyler; R Mumm; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  2 in total

1.  The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.

Authors:  H Knauf; M A Bailey; G Hasenfuss; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  2006-09-09       Impact factor: 2.953

2.  A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease.

Authors:  Bertrand Dussol; Julie Moussi-Frances; Sophie Morange; Claude Somma-Delpero; Olivier Mundler; Yvon Berland
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-09       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.